Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Gustavo S Oderich
Study ID
NCT01937949
Status
Recruiting

Conditions

  • Juxtarenal Aortic Aneurysms
  • Suprarenal Aortic Aneurysms
  • Type IV Thoracoabdominal Aortic Aneurysms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Custom-made Zenith® Fenestrated AAA Endovascular Graft: — DEVICE
    The graft will be inserted through arteries in the groin (called endovascular repair). Endovascular repair is a procedure that uses catheters that go inside your blood vessel to place a stent graft above and below the aneurysm. This procedure lines the aneurysm with a new lining (stent) so blood does not fill the artery any more.

Study Details

The purpose of this study is to evaluate clinical outcomes and quality of life measures in treated by endovascular aortic repair of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft.

Key Dates

Start date
Aug 31, 2013
Status verified
Jan 2026
Primary completion
Mar 31, 2025
Completion
May 31, 2030

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Endovascular
    The study will include patients treated by endovascular aortic repair of juxtarenal, suprarenal and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft. The graft includes combinations of scallops, holes (fenestrations) or cuffs (side branches) . These small holes or branches are the investigational part of this research study. The arteries to the liver, intestine, and kidneys will be have a stent (small tubular stainless steel structures) to help keep the arteries open and aligned with the fenestrations or branches. Other names: Endovascular stent Stent-graft

Primary Outcome Measure

Number of subjects who have die at 30 days post treatment [ Time Frame: 30 days post treatment] ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-
The University of Texas Health Science Center at HoustonHoustonTexas77030
Mariano R Montemayor, MD, MHA, CCRP
(713) 486-5194
Naveed U Saqib, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN